Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

12.60p
   
  • Change Today:
      2.70p
  • 52 Week High: 17.60
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 4,708,832
  • Market Cap: £63.34m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £187,546
Lisa Baderoon 583,963 £73,579
Tim Franklin 525,000 £66,150

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £3,163,614
Luca & Associates AG 22,000,000 £2,772,000
Invesco Ltd 17,872,341 £2,251,915
Aviva Investors Global 11,285,180 £1,421,933
Alora Pharmaceuticals LLC 10,909,091 £1,374,546
M&G Investments 7,600,000 £957,600
Prudential plc 7,600,000 £957,600
Capital Income Builder 4,870,367 £613,666
Dr R Zimmer 4,551,553 £573,496
Odey Asset Management 3,433,319 £432,598
Rhone Trustees (Switzerland) SA 3,386,000 £426,636
Pictet Overseas Trust Corporation Limited 3,287,500 £414,225

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 12.60p
Change Today 2.70p
% Change 27.27 %
52 Week High 17.60
52 Week Low 1.09
Volume 4,708,832
Shares Issued 502.72m
Market Cap £63.34m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 17-Oct-2025

Time Volume / Share Price
16:04 165,000 @ 11.83p
16:29 50,000 @ 12.60p
16:28 81,784 @ 12.39p
16:16 56,937 @ 12.50p
16:16 75,000 @ 12.10p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page